Antimicrobial Performance of a Novel Drug-Eluting Bioenvelope

Area of Science:

• Biomaterials Science
• Infectious Disease Prevention
• Medical Device Technology

Background:

• Infections associated with cardiac implantable electronic devices (CIEDs) and neurostimulators pose significant risks to patient outcomes.
• Effective prevention strategies are crucial for optimizing the safety and efficacy of these implanted devices.

Purpose of the Study:

• To evaluate the antimicrobial performance of a novel biologic CIED envelope.
• The envelope incorporates a bioabsorbable disc infused with rifampin and minocycline.

Main Methods:

• Antimicrobial activity was assessed using a rabbit model and in vitro elution tests.
• A modified AATCC-100 method was employed to quantify antibacterial activity against seven relevant bacterial strains.
• In vivo-in vitro correlation studies guided the methodology.

Main Results:

• Pharmacokinetic analysis revealed a biphasic elution profile for the antibiotics over 14 days.
• The modified AATCC-100 tests demonstrated complete bacterial eradication across all tested species.
• No bacterial recovery was observed in any replicate, indicating potent antimicrobial action.

Conclusions:

• Antibiotic-eluting bioenvelopes represent a viable strategy for preventing CIED-related bacterial infections.
• The study introduces a modified AATCC-100 test and in vivo-in vitro correlation as valuable tools for evaluating implantable biomaterial antimicrobial activity.